Results 261 to 270 of about 792,865 (388)

De Novo Heterozygous ZFX Frameshift Variant in a Female With an X‐Linked Neurodevelopmental Disorder

American Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Germline ZFX variants are associated with an X‐linked neurodevelopmental disorder, with 14 males and 16 females reported to date. We describe a 20‐year‐old female with a heterozygous ZFX frameshift variant, p.(Met666Valfs*2), identified by genome sequencing, previously reported in an affected male.
Iftekhar A. Showpnil, Allison Daley, Emily R. Sites, Shayne M. Plourde, Jesse M. Hunter, Dennis W. Bartholomew, April N. Lehman, Daniel C. Koboldt, Rolf W. Stottmann   +8 more
wiley   +1 more source

Inflammation-mediated regional brain alterations associated with mild cognitive impairment in knee osteoarthritis. [PDF]

Arthritis Res Ther
Li C, Hao C, Zhou K, Zhang P, Sun Q, Li Z.   +5 more
europepmc   +1 more source

Connected speech and language in mild cognitive impairment and Alzheimer’s disease: A review of picture description tasks

Journal of Clinical and Experimental Neuropsychology, 2018
Kimberly D. Mueller, B. Hermann, Jonilda Mecollari, L. Turkstra   +3 more
semanticscholar   +1 more source

The Multifaceted Etiology of Mental Disorders With a Focus on Trace Elements, a Review of Recent Literature

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, EarlyView.
ABSTRACT Mental disorders are a significant global public health concern, affecting nearly one in eight individuals worldwide. This review investigates the multifaceted etiology of mental disorders—specifically major depressive disorder (MDD), schizophrenia (SCZ), and bipolar disorder (BD)—through genetic, neurobiological, and environmental ...
Maria Francesca Astorino, Marco Calabrò, Carmenrita Infortuna, Maria Rosaria Anna Muscatello, Silvana Briuglia, Nicola Cicero, Chiara Fabbri, Alessandro Serretti, Concetta Crisafulli   +8 more
wiley   +1 more source

Fibre-specific white matter reductions in Alzheimer’s disease and mild cognitive impairment

Brain : a journal of neurology, 2018
R. Mito, D. Raffelt, T. Dhollander, D. Vaughan, J. Tournier, Olivier Salvado, A. Brodtmann, C. Rowe, V. Villemagne, A. Connelly   +9 more
semanticscholar   +1 more source

Neurodevelopmental Phenotyping and Genotyping in the Pediatric National Institute of Health Undiagnosed Disease Program

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, EarlyView.
ABSTRACT The National Institute of Health (NIH) Undiagnosed Diseases Program (UDP) is an NIH project with the goal of providing both a comprehensive diagnosis and a better understanding of the many mechanisms of disease for patients with rare and undiagnosed conditions.
Dee Adedipe, Audrey Thurm, Lisa Joseph, Maria T. Acosta, Ellen F. Macnamara, Colby Chlebowski, Riley Kessler, Precilla D'Souza, Lynne Wolfe, Jean M. Johnson, Tyra Estwick, John Yang, Paul R. Lee, Jennifer Murphy, Camilo Toro, Thomas Markello, Dennis Carter, David R. Adams, William A. Gahl, Cynthia J. Tifft   +19 more
wiley   +1 more source

Effect of aspirin use on conversion risk from mild cognitive impairment to Alzheimer's disease. [PDF]

Front Aging Neurosci
Choi BK, Jin Y, Lee H, Kim SW, Park S, Hong I, Baek MS.   +6 more
europepmc   +1 more source

Erratum to “Structural correlates of mild cognitive impairment” [Neurobiology of Aging 25 (2004) 913–924]

, 2004
Henrike Wolf, Anke Hensel, Frithjof Kruggel, Steffi G. Riedel‐Heller, Thomas Arendt, Lars‐Olof Wahlund, Hermann‐Josef Gertz   +6 more
openalex   +1 more source

The diagnosis and management of mild cognitive impairment: a clinical review.

Journal of the American Medical Association (JAMA), 2014
K. Langa, D. Levine
semanticscholar   +1 more source

Appraisal of Gene Expression‐Based Classifiers for Neuropsychiatric Disorders: A Meta‐Regression

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, EarlyView.
ABSTRACT A substantial body of research examines the potential of gene‐expression‐based biomarkers for diagnosing and selecting treatments for neuropsychiatric disorders, yet no clear consensus has been reached regarding the influence of controllable factors such as study design and model selection on the performance of gene‐expression‐based ...
Ali Razavi, Brittany Arensman, Eric J. Barnett, Leo A. Lee, Stephen V. Faraone, Stephen J. Glatt, Jonathan L. Hess   +6 more
wiley   +1 more source